These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18295396)

  • 1. Participation of OCT3/4 and beta-catenin during dysgenetic gonadal malignant transformation.
    Palma I; Peña RY; Contreras A; Ceballos-Reyes G; Coyote N; Eraña L; Kofman-Alfaro S; Queipo G
    Cancer Lett; 2008 May; 263(2):204-11. PubMed ID: 18295396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of E-cadherin and beta-catenin in germ cell tumours and in normal male fetal germ cell development.
    Honecker F; Kersemaekers AM; Molier M; Van Weeren PC; Stoop H; De Krijger RR; Wolffenbuttel KP; Oosterhuis W; Bokemeyer C; Looijenga LH
    J Pathol; 2004 Oct; 204(2):167-74. PubMed ID: 15378486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY.
    Kersemaekers AM; Honecker F; Stoop H; Cools M; Molier M; Wolffenbuttel K; Bokemeyer C; Li Y; Lau YF; Oosterhuis JW; Looijenga LH
    Hum Pathol; 2005 May; 36(5):512-21. PubMed ID: 15948118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of OCT3/4, TSPY and β-catenin as biological markers for gonadoblastoma formation and malignant germ cell tumor development in dysgenetic gonads.
    Palma I; Garibay N; Pena-Yolanda R; Contreras A; Raya A; Dominguez C; Romero M; Aristi G; Queipo G
    Dis Markers; 2013; 34(6):419-24. PubMed ID: 23396295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadoblastoma arising in undifferentiated gonadal tissue within dysgenetic gonads.
    Cools M; Stoop H; Kersemaekers AM; Drop SL; Wolffenbuttel KP; Bourguignon JP; Slowikowska-Hilczer J; Kula K; Faradz SM; Oosterhuis JW; Looijenga LH
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2404-13. PubMed ID: 16608895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor risk in disorders of sex development (DSD).
    Looijenga LH; Hersmus R; Oosterhuis JW; Cools M; Drop SL; Wolffenbuttel KP
    Best Pract Res Clin Endocrinol Metab; 2007 Sep; 21(3):480-95. PubMed ID: 17875493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OCT4: biological functions and clinical applications as a marker of germ cell neoplasia.
    Cheng L; Sung MT; Cossu-Rocca P; Jones TD; MacLennan GT; De Jong J; Lopez-Beltran A; Montironi R; Looijenga LH
    J Pathol; 2007 Jan; 211(1):1-9. PubMed ID: 17117392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell factor as a novel diagnostic marker for early malignant germ cells.
    Stoop H; Honecker F; van de Geijn GJ; Gillis AJ; Cools MC; de Boer M; Bokemeyer C; Wolffenbuttel KP; Drop SL; de Krijger RR; Dennis N; Summersgill B; McIntyre A; Shipley J; Oosterhuis JW; Looijenga LH
    J Pathol; 2008 Sep; 216(1):43-54. PubMed ID: 18566970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXL2 and SOX9 distinguish the lineage of the sex cord-stromal cells in gonadoblastomas.
    Buell-Gutbrod R; Ivanovic M; Montag A; Lengyel E; Fadare O; Gwin K
    Pediatr Dev Pathol; 2011; 14(5):391-5. PubMed ID: 21682576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into type II germ cell tumor pathogenesis based on studies of patients with various forms of disorders of sex development (DSD).
    Hersmus R; de Leeuw BH; Wolffenbuttel KP; Drop SL; Oosterhuis JW; Cools M; Looijenga LH
    Mol Cell Endocrinol; 2008 Sep; 291(1-2):1-10. PubMed ID: 18403106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation and development of human female germ cells during prenatal gonadogenesis: an immunohistochemical study.
    Stoop H; Honecker F; Cools M; de Krijger R; Bokemeyer C; Looijenga LH
    Hum Reprod; 2005 Jun; 20(6):1466-76. PubMed ID: 15734757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXL2 and SOX9 as parameters of female and male gonadal differentiation in patients with various forms of disorders of sex development (DSD).
    Hersmus R; Kalfa N; de Leeuw B; Stoop H; Oosterhuis JW; de Krijger R; Wolffenbuttel KP; Drop SL; Veitia RA; Fellous M; Jaubert F; Looijenga LH
    J Pathol; 2008 May; 215(1):31-8. PubMed ID: 18348162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 46 XY pure gonadal dysgenesis with gonadoblastoma and dysgerminoma.
    Ben Temime R; Chachial A; Attial L; Ghodbanel I; Makhloufl T; Koubaal A; Kourda N; Ben Jilani S; Dammak T; El May A; Rahal K
    Tunis Med; 2008 Jul; 86(7):710-3. PubMed ID: 19472738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadoblastoma-associated mixed germ cell tumour in 46,XY complete gonadal dysgenesis (Swyer syndrome): analysis of Y chromosomal genotype and OCT3/4 and TSPY expression profile.
    Ng SB; Yong MH; Knight LA; Lee VK; Nadarajah S; Stoop H; Looijenga LH
    Histopathology; 2008 Apr; 52(5):644-6. PubMed ID: 18312345
    [No Abstract]   [Full Text] [Related]  

  • 15. Bilateral gonadoblastomas in a dog with mixed gonadal dysgenesis.
    Reis-Filho JS; Ricardo S; Gärtner F; Schmitt FC
    J Comp Pathol; 2004; 130(2-3):229-33. PubMed ID: 15003485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights.
    Looijenga LH
    J Pathol; 2009 Jun; 218(2):146-62. PubMed ID: 19253916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of Y-chromosome-bearing cells in gonadoblastoma and dysgenetic testis in 45,X/46,XY infants.
    Peña-Alonso R; Nieto K; Alvarez R; Palma I; Nájera N; Eraña L; Dorantes LM; Kofman-Alfaro S; Queipo G
    Mod Pathol; 2005 Mar; 18(3):439-45. PubMed ID: 15475933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E-cadherin/beta-catenin/T-cell factor pathway is involved in smooth muscle cell proliferation elicited by oxidized low-density lipoprotein.
    Bedel A; Nègre-Salvayre A; Heeneman S; Grazide MH; Thiers JC; Salvayre R; Maupas-Schwalm F
    Circ Res; 2008 Sep; 103(7):694-701. PubMed ID: 18703780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of c-KIT mutations in gonadoblastoma and dysgerminomas of patients with disorders of sex development (DSD) and ovarian dysgerminomas.
    Hersmus R; Stoop H; van de Geijn GJ; Eini R; Biermann K; Oosterhuis JW; Dhooge C; Schneider DT; Meijssen IC; Dinjens WN; Dubbink HJ; Drop SL; Looijenga LH
    PLoS One; 2012; 7(8):e43952. PubMed ID: 22937135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the Y-containing cell line on histological differentiation patterns in dysgenetic gonads.
    Cools M; Boter M; van Gurp R; Stoop H; Poddighe P; Lau YF; Drop SL; Wolffenbuttel KP; Looijenga LH
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):184-92. PubMed ID: 17547684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.